{"id":594494,"date":"2019-10-31T04:07:16","date_gmt":"2019-10-31T04:07:16","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/"},"modified":"2019-10-31T04:07:16","modified_gmt":"2019-10-31T04:07:16","slug":"rameda-announces-intention-to-ipo-in-4q2019","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","title":{"rendered":"Rameda announces intention to IPO in 4Q2019"},"content":{"rendered":"

<\/a> IPO WATCH- Rameda announces intention to IPO in 4Q2019:<\/b> Rameda Pharma<\/a>, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors as well as a retail offering. The value of the offering was not disclosed.<\/p>\n

Rameda would be the second company to go public on the EGX<\/b> in 2019 after Fawry made its trading debut in August.<\/a><\/p>\n

Who\u2019s selling?<\/b> According to the ITF (pdf)<\/a>, Greville Investing is the selling shareholder.<\/p>\n

Use of proceeds: <\/b>Greville will reinject a portion of its proceeds from the transaction to subscribe to at least EGP 650 mn in newly-issued shares. Rameda plans to use the injection to fund operational expansions, with options on the table including the acquisition of new molecules and, potentially, the \u201copportunistic acquisition of pharmaceutical companies.\u201d Rameda CEO Amr Morsy said the company look forward to further expand and continue growing across Egypt and the Middle East, noting that Rameda plans to introduce new products in Egypt and work on new export markets.<\/p>\n

\"\"<\/a><\/p>\n

The financials: <\/b>Rameda\u2019s revenues for FY2018 grew about 27% y-o-y to EGP 805.2 mn, giving it a 2016-18 revenue CAGR of about 43%; adjusted EBITDA grew at a CAGR of about 67% in the same period. Profits last year stood at EGP 129 mn, up from EGP 89 mn the previous year and EGP 27 mn in 2016.<\/p>\n

Background: <\/b>Rameda is formally the Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents SAE. The company was one of at least three Egyptian companies believed to have pulled IPOs<\/a> after the emerging market meltdown in the second half of last year.<\/p>\n

Advisers: HSBC<\/b> and Investec<\/b> are joint global coordinators and bookrunners for the international offering, while CI Capital<\/b> is joint bookrunner. Inktank<\/b><\/a> is investor relations advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO WATCH- Rameda announces intention to IPO in 4Q2019: Rameda Pharma, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors as well as a retail […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[68,72,76,490,78,427,449,11094,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-594494","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-egx","tag-enterpriseam","tag-financial-regulatory-authority","tag-hsbc","tag-ipo-watch","tag-pharma","tag-rameda-pharma","tag-sharesale","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"5202f764-787a-4158-8182-c843cc1debd8","is_powered_by":true,"story_type":"1","photo_url":"","photo_position":"above","related_issue":[594489],"teaser":"","voice_url":""},"yoast_head":"\nRameda announces intention to IPO in 4Q2019 - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rameda announces intention to IPO in 4Q2019\" \/>\n<meta property=\"og:description\" content=\"IPO WATCH- Rameda announces intention to IPO in 4Q2019: Rameda Pharma, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors as well as a retail […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-31T04:07:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ent.news\/2019\/10\/2047.jpg\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Rameda announces intention to IPO in 4Q2019\",\"datePublished\":\"2019-10-31T04:07:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\"},\"wordCount\":315,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ent.news\/2019\/10\/2047.jpg\",\"keywords\":[\"EGX\",\"EnterpriseAM\",\"Financial Regulatory Authority\",\"HSBC\",\"IPO watch\",\"pharma\",\"Rameda Pharma\",\"Sharesale\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\",\"name\":\"Rameda announces intention to IPO in 4Q2019 - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ent.news\/2019\/10\/2047.jpg\",\"datePublished\":\"2019-10-31T04:07:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage\",\"url\":\"https:\/\/ent.news\/2019\/10\/2047.jpg\",\"contentUrl\":\"https:\/\/ent.news\/2019\/10\/2047.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rameda announces intention to IPO in 4Q2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rameda announces intention to IPO in 4Q2019 - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","og_locale":"en_US","og_type":"article","og_title":"Rameda announces intention to IPO in 4Q2019","og_description":"IPO WATCH- Rameda announces intention to IPO in 4Q2019: Rameda Pharma, the country\u2019s fastest-growing generic pharmaceuticals player, announced yesterday morning its intention to sell an undisclosed number of shares in an initial public offering on the EGX in 4Q2019. The company is planning an offering to institutional and international investors as well as a retail […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2019-10-31T04:07:16+00:00","og_image":[{"url":"https:\/\/ent.news\/2019\/10\/2047.jpg","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Rameda announces intention to IPO in 4Q2019","datePublished":"2019-10-31T04:07:16+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/"},"wordCount":315,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage"},"thumbnailUrl":"https:\/\/ent.news\/2019\/10\/2047.jpg","keywords":["EGX","EnterpriseAM","Financial Regulatory Authority","HSBC","IPO watch","pharma","Rameda Pharma","Sharesale","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","url":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/","name":"Rameda announces intention to IPO in 4Q2019 - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage"},"thumbnailUrl":"https:\/\/ent.news\/2019\/10\/2047.jpg","datePublished":"2019-10-31T04:07:16+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#primaryimage","url":"https:\/\/ent.news\/2019\/10\/2047.jpg","contentUrl":"https:\/\/ent.news\/2019\/10\/2047.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/10\/31\/rameda-announces-intention-to-ipo-in-4q2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Rameda announces intention to IPO in 4Q2019"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":593412,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/27\/rameda-prices-its-ipo-at-egp-4-66-per-share\/","url_meta":{"origin":594494,"position":0},"title":"Rameda prices its IPO at EGP 4.66 per share","author":"enterpriseam admin","date":"27 November 2019","format":false,"excerpt":"IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will offer 376,606,000 shares at a price of EGP 4.66 per ordinary share in an initial public offering on the EGX. The Arabic-language public subscription notice (PSN) to local investors is\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591230,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/01\/rameda-pharma-retail-offering-oversubscribed-on-first-day\/","url_meta":{"origin":594494,"position":1},"title":"Rameda Pharma retail offering oversubscribed on first day","author":"enterpriseam admin","date":"1 December 2019","format":false,"excerpt":"IPO WATCH- Rameda Pharma retail offering oversubscribed on first day: The retail component of Rameda\u2019s IPO was oversubscribed at the close of play on Thursday, market sources told the local press. Retail investors put in orders for 19.65 mn shares, handily covering the 18.83 mn shares offered by the pharma\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":593462,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/28\/fra-gives-rameda-green-light-on-public-subscription-notice\/","url_meta":{"origin":594494,"position":2},"title":"FRA gives Rameda green light on public subscription notice","author":"enterpriseam admin","date":"28 November 2019","format":false,"excerpt":"IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda Pharma\u2019s public subscription notice (pdf) to local investors for its initial public offering on the EGX, according to a statement to the bourse (pdf). Rameda has announced (pdf) that it\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":591422,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/05\/rameda-pharma-retail-subscription-surges-on-final-day-offering-closes-33x-oversubscribed\/","url_meta":{"origin":594494,"position":3},"title":"Rameda Pharma retail subscription surges on final day, offering closes 33x oversubscribed","author":"enterpriseam admin","date":"5 December 2019","format":false,"excerpt":"Retail appetite for Rameda\u2019s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma\u2019s 5% public offering on the final day of subscription yesterday, leading the retail component to close 36.3x oversubscribed, Al Mal reports. Investors had placed orders for 683.22 mn shares by the\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2020\/1\/626.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":593231,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/11\/21\/rameda-receives-greenlight-for-ipo-this-year\/","url_meta":{"origin":594494,"position":4},"title":"Rameda receives greenlight for IPO this year","author":"enterpriseam admin","date":"21 November 2019","format":false,"excerpt":"IPO WATCH- Rameda gets nod for share listing, will go public before the end of the year \u2013FRA: Rameda Pharma has received approval from the Financial Regulatory Authority (FRA) to go public on the EGX before the end of this year, FRA boss Mohamed Omran said at a press conference\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2019\/8\/EGX-1600px.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":595175,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/09\/18\/is-rameda-pharma-the-mysterious-pharma-company-planning-a-usd-61mn-ipo\/","url_meta":{"origin":594494,"position":5},"title":"Is Rameda Pharma the mysterious pharma company planning a USD 61mn IPO?","author":"enterpriseam admin","date":"18 September 2019","format":false,"excerpt":"IPO WATCH- Is Rameda Pharma the mysterious pharma company planning a USD 61mn IPO? Remember that unnamed pharma company that Financial Regulatory Authority official Sayed Abdel Fadeel said is planning a USD 61 mn initial public offering on the EGX this year? Well, Al Mal is speculating that the company\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/594494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=594494"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/594494\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/594489"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=594494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=594494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=594494"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=594494"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=594494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}